ILM1.DE

ILM1.DE

XETRA

Medios AG

13.72

-0.09999973(-0.72%)
Volume

0.0M

Market Cap

$349.94M

P/E Ratio

25.74

EPS

$0.51


Price Chart

Price Alerts

No price alerts set. Add an alert to get notified!

Notify when price goes above $120.00
Notify when price goes above $180.00
Notify when price goes below $180.00

Key Financial Ratios

P/E Ratio

25.74

P/B Ratio

0.63

EPS

$0.51

ROE

2.46%

Profit Margin

0.67%

Operating Margin

1.68%

Peer Comparison

Compare TSM with similar companies in the sector

Company Price Change % P/E Market Cap D/E
2LYA.F
High Tide Inc.
$2.32 8.16% -5.79 $203.79M 1.71
6H90.SG
Healwell AI Inc
$0.59 2.51% -3.82 $174.41M 0.74
94E.F
Zura Bio Limited
$5.40 0.93% -9.50 $351.12M 0.00
FYB.DE
Formycon AG
$18.94 -1.97% -1.97 $335.43M 0.02
HPHA.DE
Heidelberg Pharma AG
$3.17 4.28% -5.71 $148.31M 0.01
LIK.DE
LIMES Schlosskliniken AG
$490.00 0.00 31.25 $143.66M 0.56
M12.DE
M1 Kliniken AG
$15.34 -1.16% 16.04 $288.06M 0.18
MED.DE
Mediclin AG
$3.50 0.00 4.74 $166.25M 1.81
NP5.DE
Newron Pharmaceuticals S.p.A.
$18.22 0.00 13.86 $363.69M 33.23
SBS.DE
Stratec SE
$18.71 -1.53% 14.53 $227.44M 0.55

* Peer stocks are selected based on market capitalization and sector

Private Notes

Key Statistics

52 Week High

$17.44

52 Week Low

$9.98

Dividend

$0.00

Dividend Yield

0.00%

About Medios AG

Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies; and patient-specific therapies for dispensing individually dosed tablets. The company was founded in 2016 and is based in Berlin, Germany.